Inpatient and Outpatient Orderable

Renal Cancer Panel Build info

Synonyms

  • RENAL CANCER PANEL
  • LAB155109

Short Name

RENAL CANCER PANEL

Procedure Master Number

LAB155109

Procedure ID

155109

Clinical Info

This test is appropriate for patients to verify the genetic basis of cancer in families indicative or suggestive of a predisposition to renal cancer. VHL, MET, FLCN, FH, TSC1 and TSC2 are the genes that are the most often associated with classic forms of hereditary renal cancer, there are several other genes that cause an increased risk of renal cancer. For example, if the family history consists of multiple types of cancer, such as renal cancer in addition to pancreatic cancer, this may be associated with a cancer syndrome such as VHL or Lynch syndrome. Results may help in determining treatment and management, as well as identification of at-risk family members.

Specimen Sources

 Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

 Blood

Container

Lavender Top Tube or Buccal (Oral Cheek Swab)

Collection Instructions

Container/Tube:  Lavender top tube
Specimen:  2 - 5 mL Whole Blood
 
Note:   Test requires indication for testing and family history submitted  with specimen

Transport Instructions

Room Temperature

Specimen Stability

Methodology

Genotyping by Next Generation Sequencing
 
Genes:
 BAP1, EPCAM, FH, FLCN, MET, MITF, MLH1, MSH2, MSH6, PMS2, PTEN, SDHB, SDHC, SDHD, TP53, TSC1, TSC2, VHL

Days Performed

TAT:  21-29 Days

Performing Laboratory

GeneDx

CPT

81435

PDM

 1659884

Only Orderable at Locations:

 Orderable Everywhere

Results
Component Name Base Name Common Name External Name
RENAL CELL CANCER PANEL RENCAP RENAL CELL CANCER PANEL Renal Cell Cancer Panel

Forms
edit